Your browser doesn't support javascript.
loading
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms.
Kongkiatkamon, Sunisa; Terkawi, Laila; Guan, Yihong; Adema, Vera; Hasipek, Metis; Dombrovski, Tatiana; Co, Milo; Walter, Wencke; Awada, Hassan; Parker, Yvonne; Hutter, Stephan; Pagliuca, Simona; Gurnari, Carmelo; Rogers, Heesun J; Meggendorfer, Manja; Lindner, Daniel J; Haferlach, Torsten; Visconte, Valeria; LaFramboise, Thomas; Jha, Babal K; Maciejewski, Jaroslaw P.
Afiliação
  • Kongkiatkamon S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Terkawi L; Research Unit in Translational Hematology, Division of Hematology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Guan Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Adema V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hasipek M; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Dombrovski T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Co M; Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Walter W; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Awada H; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Parker Y; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Hutter S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Pagliuca S; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Rogers HJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Meggendorfer M; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA.
  • Lindner DJ; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Haferlach T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Visconte V; MLL Munich Leukemia Laboratory, Munich, Germany.
  • LaFramboise T; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Jha BK; Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Leukemia ; 36(8): 2086-2096, 2022 08.
Article em En | MEDLINE | ID: mdl-35761024

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Transtornos Mieloproliferativos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia / Transtornos Mieloproliferativos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido